Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337

1.

Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.

Li P, Gu J, Yang X, Cai H, Tao J, Yang X, Lu Q, Wang Z, Yin C, Gu M.

PLoS One. 2013 Aug 20;8(8):e71604. doi: 10.1371/journal.pone.0071604. eCollection 2013.

2.

The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.

Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, Ankathil R.

Cancer Epidemiol. 2013 Oct;37(5):634-8. doi: 10.1016/j.canep.2013.05.007. Epub 2013 Jun 24.

PMID:
23806437
3.

The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.

Li X, Gao Y, Zhou H, Xu W, Li P, Zhou J, Xu T, Yu B, Xu Z, Zou Q, Yin C, Cai H, Shen W.

Cancer Biomark. 2016;16(1):11-7. doi: 10.3233/CBM-150536.

PMID:
26484607
4.

A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.

Cai H, Sun L, Cui L, Cao Q, Qin C, Zhang G, Mao X, Wang M, Zhang Z, Shao P, Yin C.

Urol Int. 2013;91(2):206-12. doi: 10.1159/000345630. Epub 2012 Dec 29.

PMID:
23295440
5.

Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.

Huo ZH, Zhong HJ, Zhu YS, Xing B, Tang H.

Genet Mol Res. 2013 Mar 11;12(3):3435-43. doi: 10.4238/2013.March.11.6.

6.

Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese.

Tang T, Cui S, Deng X, Gong Z, Jiang G, Wang P, Liao B, Fei Z, Xian S, Zeng D, Li J.

DNA Cell Biol. 2010 Jan;29(1):9-12. doi: 10.1089/dna.2009.0937.

PMID:
19778281
7.

The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.

Eskandari-Nasab E, Hashemi M, Ebrahimi M, Amininia S.

Cancer Biomark. 2016;16(1):109-15. doi: 10.3233/CBM-150546.

PMID:
26835711
8.

Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.

Lo SS, Chen JH, Wu CW, Lui WY.

Surgery. 2009 Mar;145(3):280-5. doi: 10.1016/j.surg.2008.11.001.

PMID:
19231580
9.

Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: an updated meta-analysis.

Duan W, Wang E, Zhang F, Wang T, You X, Qiao B.

Cancer Invest. 2014 Aug;32(7):311-20. doi: 10.3109/07357907.2014.911881. Epub 2014 May 14.

PMID:
24827594
10.

Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population.

Lai HM, Li XM, Yang YN, Ma YT, Xu R, Pan S, Zhai H, Liu F, Chen BD, Zhao Q.

PLoS One. 2015 Jun 15;10(6):e0129144. doi: 10.1371/journal.pone.0129144. eCollection 2015.

11.

NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population.

Fan Y, Yu W, Ye P, Wang H, Wang Z, Meng Q, Duan Y, Liang X, An W.

DNA Cell Biol. 2011 Apr;30(4):241-5. doi: 10.1089/dna.2010.1107. Epub 2010 Dec 7.

PMID:
21138333
12.

NFKB1 -94 insertion/deletion ATTG polymorphism contributes to risk of systemic lupus erythematosus.

Gao M, Wang CH, Sima X, Han XM.

DNA Cell Biol. 2012 Apr;31(4):611-5. doi: 10.1089/dna.2011.1389. Epub 2011 Oct 20.

PMID:
22013908
13.

Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer.

Riemann K, Becker L, Struwe H, Rübben H, Eisenhardt A, Siffert W.

Int J Clin Pharmacol Ther. 2007 Aug;45(8):423-30.

PMID:
17725175
14.

A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer.

Wang M, Zhang Z, Tian Y, Shao J, Zhang Z.

Clin Cancer Res. 2009 Apr 1;15(7):2567-72. doi: 10.1158/1078-0432.CCR-08-2829. Epub 2009 Mar 10.

15.

A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer.

Zhang P, Wei Q, Li X, Wang K, Zeng H, Bu H, Li H.

Cancer Genet Cytogenet. 2009 Jun;191(2):73-7. doi: 10.1016/j.cancergencyto.2009.01.017.

PMID:
19446741
16.

The NFKB1 -94 ATTG insertion/deletion polymorphism (rs28362491) contributes to the susceptibility of congenital heart disease in a Chinese population.

Zhang D, Li L, Zhu Y, Zhao L, Wan L, Lv J, Li X, Huang P, Wei L, Ma M.

Gene. 2013 Mar 10;516(2):307-10. doi: 10.1016/j.gene.2012.12.078. Epub 2013 Jan 5.

PMID:
23299027
17.

Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.

Wang D, Xie T, Xu J, Wang H, Zeng W, Rao S, Zhou K, Pei F, Zhou Z.

Sci Rep. 2016 Jul 22;6:30220. doi: 10.1038/srep30220.

18.

Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients.

Mishra A, Srivastava A, Mittal T, Garg N, Mittal B.

Cytokine. 2013 Mar;61(3):856-61. doi: 10.1016/j.cyto.2012.12.020. Epub 2013 Jan 26.

PMID:
23357300
19.

Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.

Yin J, Wang H, Vogel U, Wang C, Hou W, Ma Y.

Tumour Biol. 2016 Apr;37(4):5467-73. doi: 10.1007/s13277-015-4373-3. Epub 2015 Nov 13.

PMID:
26563375
20.

The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations.

Vogel U, Jensen MK, Due KM, Rimm EB, Wallin H, Nielsen MR, Pedersen AP, Tjønneland A, Overvad K.

Atherosclerosis. 2011 Nov;219(1):200-4. doi: 10.1016/j.atherosclerosis.2011.06.018. Epub 2011 Jun 17.

Supplemental Content

Support Center